Continuous Bioprocessing Market Research: Size, Industry Analysis, Growth, and Opportunities - Forecasting to 2028
In August 2023, Sartorius collaborated with Repligen Corporation and launched the Integrated bioreactor system. This system incorporates Repligen XCell ATF upstream intensification technology into Sartorius' Biostat STR bioreactor to simplify intensified seed train and N perfusion implementation for biopharmaceutical manufacturers.
View full press release